MedTrace Logo

Non-enrolment and Non-adherence to HIV Care in a Community-based Program, Rakai, Uganda

NCT02135003 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1209

Last updated 2014-05-09

No results posted yet for this study

Summary

Hypothesis 1: The proportion of pre-ART patients whose CD4 cell counts decline to ART-eligibility within 48 weeks will be lower in intervention compared to the non-intervention arm.

Hypothesis 2: PLHIV who receive the PSCB intervention will experience lower rates of morbidity or death over the follow-up period compared to patients not receiving the intervention

Hypothesis 3: PLHIV who receive the PCSB intervention will have better adherence to scheduled clinic appointments compared to those not receiving the intervention

Conditions

  • CD4 Deficiency
  • Adherence
  • Quality of Life

Interventions

OTHER

patient-selected care buddy

Patient-selected Care buddy intervention: In addition to standard of care, pre-ART patients randomized to this arm were requested to choose a care buddy who was aware of the patient's HIV infection and resided in the same household or in close proximity. Care buddies attended at least two HIV health education sessions similar to those provided to study participants. Information on HIV, and the importance of adhering to scheduled clinic visits and to prescribed medications will be emphasized. Buddies were requested to remind participants to take their prophylactic treatments, and remind them of clinic appointments

Sponsors & Collaborators

  • Rakai Health Sciences Program

    lead OTHER

Principal Investigators

  • Gertrude Nakigozi, MBChB,MPH · Rakai Health Sciences Program

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02135003 on ClinicalTrials.gov